AAAAAA
Results:
1-24
|
Results: 24
Authors:
Jarvis, B
Perry, CM
Citation: B. Jarvis et Cm. Perry, Management of chronic hepatitis B - Defining the role of lamivudine, DIS MANAG H, 9(4), 2001, pp. 215-234
Authors:
Perry, CM
Goa, KL
Citation: Cm. Perry et Kl. Goa, Community-acquired pneumonia and its management - The role of levofloxacin, DIS MANAG H, 9(1), 2001, pp. 43-64
Authors:
Wellington, K
Perry, CM
Citation: K. Wellington et Cm. Perry, Venlafaxine extended-release - A review of its use in the management of major depression, CNS DRUGS, 15(8), 2001, pp. 643-669
Authors:
Plosker, GL
Perry, CM
Goa, KL
Citation: Gl. Plosker et al., Efavirenz - A pharmacoeconomic review of its use in HIV infection, PHARMACOECO, 19(4), 2001, pp. 421-440
Authors:
McClellan, K
Perry, CM
Citation: K. Mcclellan et Cm. Perry, Oseltamivir: a review of its use in influenza (vol 61, pg 263, 2001), DRUGS, 61(6), 2001, pp. 775-775
Authors:
Perry, CM
Jarvis, B
Citation: Cm. Perry et B. Jarvis, Linezolid - A review of its use in the management of serious Gram-positiveinfections, DRUGS, 61(4), 2001, pp. 525-551
Authors:
McClellan, K
Perry, CM
Citation: K. Mcclellan et Cm. Perry, Oseltamivir - A review of its use in influenza, DRUGS, 61(2), 2001, pp. 263-283
Authors:
Curran, MP
Perry, CM
Citation: Mp. Curran et Cm. Perry, Amisulpride - A review of its use in the management of schizophrenia, DRUGS, 61(14), 2001, pp. 2123-2150
Authors:
Dunn, CJ
Wagstaff, AJ
Perry, CM
Plosker, GL
Goa, KL
Citation: Cj. Dunn et al., Cyclosporin - An updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral((R)))(1) in organ transplantation, DRUGS, 61(13), 2001, pp. 1957-2016
Authors:
Mena, I
Fischer, C
Gebhard, JR
Perry, CM
Harkins, S
Whitton, JL
Citation: I. Mena et al., Coxsackievirus infection of the pancreas: Evaluation of receptor expression, pathogenesis, and immunopathology, VIROLOGY, 271(2), 2000, pp. 276-288
Authors:
Scott, LJ
Perry, CM
Citation: Lj. Scott et Cm. Perry, Delavirdine - A review of its use in HIV infection, DRUGS, 60(6), 2000, pp. 1411-1444
Authors:
Hervey, PS
Perry, CM
Citation: Ps. Hervey et Cm. Perry, Abacavir - A review of its clinical potential in patients with HIV infection, DRUGS, 60(2), 2000, pp. 447-479
Authors:
Scott, LJ
Perry, CM
Citation: Lj. Scott et Cm. Perry, Tramadol - A review of its use in perioperative pain, DRUGS, 60(1), 2000, pp. 139-176
Authors:
Ormrod, D
Scott, LJ
Perry, CM
Citation: D. Ormrod et al., Valaciclovir - A review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections, DRUGS, 59(4), 2000, pp. 839-863
Authors:
Balfour, JAB
Goa, KL
Perry, CM
Citation: Jab. Balfour et al., Alosetron, DRUGS, 59(3), 2000, pp. 511-518
Authors:
Gillies, PS
Faulds, D
Balfour, JAB
Perry, CM
Citation: Ps. Gillies et al., Ganirelix, DRUGS, 59(1), 2000, pp. 107-111
Authors:
Perry, CM
Wiseman, LR
Citation: Cm. Perry et Lr. Wiseman, Trastuzumab, BIODRUGS, 12(2), 1999, pp. 129-135
Authors:
Perry, CM
Noble, S
Citation: Cm. Perry et S. Noble, Didanosine - An updated review of its use in HIV infection, DRUGS, 58(6), 1999, pp. 1099-1135
Authors:
Perry, CM
Balfour, JAB
Lamb, HM
Citation: Cm. Perry et al., Gatifloxacin, DRUGS, 58(4), 1999, pp. 683-696
Authors:
Scott, LJ
Perry, CM
Citation: Lj. Scott et Cm. Perry, Tegaserod, DRUGS, 58(3), 1999, pp. 491-496
Authors:
Perry, CM
Lamb, HM
Citation: Cm. Perry et Hm. Lamb, Topical imiquimod - A review of its use in genital warts, DRUGS, 58(2), 1999, pp. 375-390
Authors:
Perry, CM
Markham, A
Citation: Cm. Perry et A. Markham, Piperacillin tazobactam - An updated review of its use in the treatment ofbacterial infections, DRUGS, 57(5), 1999, pp. 805-843
Authors:
Perry, CM
Balfour, JAB
Citation: Cm. Perry et Jab. Balfour, Fomivirsen, DRUGS, 57(3), 1999, pp. 375-380
Authors:
Mena, I
Perry, CM
Harkins, S
Rodriguez, F
Gebhard, J
Whitton, JL
Citation: I. Mena et al., The role of B lymphocytes in coxsackievirus B3 infection, AM J PATH, 155(4), 1999, pp. 1205-1215
Risultati:
1-24
|